BELLUS Health Inc
TSX:BLU
BELLUS Health Inc
TSX:BLU
Price:
19.48 CAD
-0.1%
Market Closed
Updated:
May 2, 2024
BELLUS Health Inc
Cash from Investing Activities
|
BELLUS Health Inc
Cash from Investing Activities Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BELLUS Health Inc
TSX:BLU
|
Cash from Investing Activities
-$135.6m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-70%
|
CAGR 10-Years
-54%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
-$6.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-149%
|
CAGR 10-Years
-67%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is BELLUS Health Inc's Cash from Investing Activities?
Cash from Investing Activities
-135.6m
USD
-135.6m
USD
Based on the financial report for Mar 31, 2023, BELLUS Health Inc's Cash from Investing Activities amounts to -135.6m USD.
What is BELLUS Health Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-54%
-54%
Over the last year, the Cash from Investing Activities growth was -281%. The average annual Cash from Investing Activities growth rates for BELLUS Health Inc have been -56% over the past three years , -70% over the past five years , and -54% over the past ten years .
You don't have any saved screeners yet
